Concepedia

Robert Vescio

RV

Statistics

Publications

86

Citations

9.1K

H-Index

43

Active since

1987

Affiliations

Cedars-Sinai Medical Center(Current)

West Los Angeles College

University of California, Los Angeles

Institute for Myeloma & Bone Cancer Research

Oncotherapeutics (United States)

Robert Vescio is an author at Cedars-Sinai Medical Center specializing in medicine, multiple myeloma, and multiple myeloma treatment.

Publications per year

1987–2023

86

Publications

86

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani et al. · The Lancet · 2016 · 850 citations

, , +14

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

, , +15

Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution

Daniel C. Douek, Robert Vescio, Michael R. Betts et al. · The Lancet · 2000 · 577 citations

, , +16

Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients

Matthew B. Rettig, Huffman K.J., Robert Vescio et al. · Science · 1997 · 481 citations

, , +15

The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

Hans Mark, Hank H. Yang, Kimberly M. Parker et al. · PubMed · 2003 · 418 citations

, , +13

1–5 of 86